Table 1.
Study | Induction of ferroptosis | Mechanism | Effects on cells | Intervention method |
---|---|---|---|---|
Zhang et al. (44) | Hcy to simulate the pathological condition of HHcy | Promotion of methylase expression and the upregulation of the GPX4 methylation. | Inducing ferroptosis in NPCs | Folic acid reducing the ability of HHcy to promote IVDD |
Bin et al. (45) | IL-6 to simulate inflammatory condition | IL-6/miR-10a-5p/IL-6R axis | Inducing ferroptosis in cartilage cells | Inhibiting miR-10a-5p and subsequently derepressing IL-6R signaling pathway |
Lu et al. (71) | TBHP to simulate oxidative stress condition | FPN downregulation and intercellular iron overload | Inducing ferroptosis in NPCs. | Enhancing the nuclear translocation of MTF1 by suppressing the JNK pathway and ameliorating the progression of IVDD |
Shan et al. (31) | Heme to simulate neovascularization condition | Increased heme catabolism, downregulation of GPX4, and intercellular iron overload, which might be mediated by the Notch pathway | Inducing ferroptosis in NPCs. | Inhibiting of the Notch signaling pathway |
Yang et al. (72) | TBHP to simulate oxidative stress condition | NCOA4-mediated ferritinophagy and intercellular iron overload | Inducing ferroptosis in NPCs and AFCs. | Silencing NCOA4 to alleviate ferroptosis |
Li et al. (114) | TBHP to simulate oxidative stress condition | Upregulation of ATF3 and ROS products | Inducing ferroptosis in NPCs. | Silencing ATF3 by miR-874-3p and alleviating IVDD |
Wang et al. (115) | FAC to simulate iron overload condition | Mineralization of endplate chondrocytes and oxidative stress | Inducing ferroptosis in endplate chondrocytes. | DFO, NAC and ferrostatin-1 rescuing high dose iron-induced IVDD and cartilage endplate calcification |
Yu et al. (116) | IL-1β to simulate inflammatory condition | Decreased NRF2 expression and upregulation of ROS products | Inducing ferroptosis in NPCs. | circ_0072464 shuttled by BMSC-secreted EVs inhibiting NPC ferroptosis by downregulation of miR-431 and upregulation of NRF2. |
IVDD, Intervertebral disc degeneration; Hcy, homocysteine; HHcy, hyperhomocysteinemia; NPCs, nucleus pulposus cells; TBHP, tert-butyl hydroperoxide; FPN, ferroportin; MTF1, metal-regulatory transcription factor 1; GPX4, glutathione peroxidase 4; NCOA4, nuclear receptor coactivator 4; AFCs, annulus fibrosus cells; ATF3, activation transcription factor 3; ROS, reactive oxygen species; FAC, ferric ammonium citrate; DFO, deferoxamine; NAC, N-acetyl-cysteine; NRF2, nuclear factor-erythroid 2 like 2; BMSC, bone marrow mesenchymal stem cells; EV, extracellular vesicle.